ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ATHX Athersys Inc

0,1018
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Athersys Inc ATHX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 0,1018 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,1018
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/1/202413:31EDGAR2Form 8-K - Current report
22/12/202323:09EDGAR2Form 8-K - Current report
21/12/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/10/202314:00EDGAR2Form 8-K - Current report
16/10/202322:52BWAthersys Extends Near Term Liquidity with Proceeds from..
12/10/202315:28EDGAR2Form 8-K - Current report
11/10/202315:27EDGAR2Form 8-K - Current report
10/10/202314:30BWAthersys Reports Interim Analysis Results of MASTERS-2..
06/10/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:41EDGAR2Form 8-K - Current report
03/10/202322:30BWAthersys Licenses its Animal Health Assets to Ardent Animal..
02/10/202323:05EDGAR2Form 8-K - Current report
02/10/202323:04BWAthersys Director Jane Wasman Appointed Board Chair
25/9/202322:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19/9/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202303:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/9/202303:04EDGAR2Form 8-K - Current report
14/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202316:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202323:13EDGAR2Form S-3 - Registration statement under Securities Act of..
11/9/202314:46EDGAR2Form 8-K - Current report
06/9/202320:45BWGrant Awarded to Newcastle University to Research Athersys’..
21/8/202320:36EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
18/8/202316:14EDGAR2Form 8-K - Current report
18/8/202303:30BWAthersys, Inc. Announces Pricing of $3.5 Million Public..
17/8/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
16/8/202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/8/202323:01BWAthersys Reports Second Quarter 2023 Financial Results and..
11/8/202314:19EDGAR2Form 8-K - Current report
11/8/202314:00BWAthersys Appoints Neema Mayhugh, PhD to its Board of..
10/8/202323:03EDGAR2Form 8-K - Current report
08/8/202314:02EDGAR2Form 8-K - Current report
07/8/202323:02EDGAR2Form S-1/A - General form for registration of securities..
31/7/202319:38BWAthersys to Host Business Update Conference Call on August..
31/7/202314:01EDGAR2Form 8-K - Current report
26/7/202315:19EDGAR2Form S-1/A - General form for registration of securities..
14/7/202322:31EDGAR2Form S-1 - General form for registration of securities under..
14/7/202322:16EDGAR2Form 8-K/A - Current report: [Amend]
06/7/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202320:04EDGAR2Form 8-K - Current report
01/6/202322:40BWPatient Enrollment Begins in Third and Final Cohort of the..
23/5/202314:30BWAthersys Restructures Debt with Supplier
18/5/202315:58BWAthersys Reports First Quarter 2023 Financial Results and..
08/5/202315:49BWAthersys to Participate in Three Upcoming Conferences
01/5/202314:30BWAthersys to Participate in The Cellular Therapies and..

Dernières Valeurs Consultées

Delayed Upgrade Clock